Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity

Kidney International

Volumn 58, Issue 3, 2000, Pages 1174-1185

  Shihab, Fuad S ^a,b   Yi, Hong ^a,b   Bennett, William M ^a,b   Andoh, Takeshi F ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Afferent arteriolar hyalinosis; Collagen; Extracellular matrix; Fibrosis; Glycoprotein; L arginine; Plasminogen activator inhibitor 1

Indexed keywords

ARGININE; BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYCLOSPORIN; FIBRONECTIN; MATRIX PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULUS FILTRATION RATE; HYALINE DEGENERATION; KIDNEY FIBROSIS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033856295     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00273.x     Document Type: Article

References (64)

1. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
2. Cyclosporine nephropathy: Pathophysiology and clinical impact
3. Cyclosporine-associated chronic nephropathy
4. Chronic cyclosporine-induced nephropathy in the rat
5. Role of transforming growth factorβ1 in experimental chronic cyclosporine nephropathy
6. Salt-depletion enhances TGFβ1 and matrix proteins expression in rat chronic cyclosporine nephropathy
7. Angiotensin II blockade decreases TGF-β1 and matrix proteins in chronic cyclosporine nephropathy
8. Localization and regulation of nitric oxide synthase isoforms in the kidney
9. Cytokines and l-arginine in renal injury and repair
10. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy
11. L-arginine administration prevents glomerular hyperfiltration, and decreases proteinuria in diabetic rats
12. Oral administration of l-arginine and captopril in rats prevents chronic renal failure by nitric oxide production
13. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy
14. Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats
15. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells
16. L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis
17. Arginine feeding modifies cyclosporine nephrotoxicity in rats
18. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of l-arginine
19. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity
20. 2+
21. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine
22. Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells
23. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms
24. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition
25. Protective effects of dietary l-arginine supplementation on chronic cyclosporine nephrotoxicity
26. Hypertensive nephrosclerosis in the Dahl/Rapp rat: Initial sites of injury and effect of dietary l-arginine administration
27. The murine transforming growth factor-β precursor
28. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1
29. Deduced protein sequence of small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species
30. Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D
31. cDNA clones completing the nucleotide and derived amino acid sequence of the alpha 1 chain of basement membrane (type IV) collagen from mouse
32. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family
33. Enzyme-linked immunoassay (ELISA) for connective tissue components
34. The long-term course of cyclosporine-associated chronic nephropathy
35. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: Evidence of a direct effect on nitric oxide synthase activity
36. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy
37. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production
38. Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus
39. Nitric oxide in renal health and disease
40. Can L-arginine manipulation reduce renal disease?
41. Nitric-oxide generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells
42. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis
43. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity
44. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-β expression with preserved renal blood flow
45. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion
46. Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells
47. Duality of nitric oxide in acute renal injury
48. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole
49. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat
50. Angiotensin II: Nitric oxide interaction and the distribution of blood flow
51. Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat
52. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors
53. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins
54. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis
55. Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures
56. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β
57. Expression of nitric oxide synthase by cytokines in vascular smooth muscle cells
58. Angiotensin II inhibits interleukin-1β-induced nitric oxide production in cultured rat mesangial cells
59. Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells
60. Apoptosis and renal scarring
61. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis
62. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients
63. Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients